Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Recruiting now

Conditions studied: Acute Myeloid Leukemia (AML)

In brief

During the last fifteen years, the landscape of AML diagnosis and therapeutical options has markedly evolved. Refined genetic and prognostic characterizations, together with new drug approvals and new allogeneic hematopoietic stem cell transplantation (HSCT) procedures, have increased patient journey diversity.

Key facts

Study ID

NCT04777916

Run by

Acute Leukemia French Association

People needed

5000

Starts

2022-04-14

Expected to finish

2046-04-01

Last updated by the study team

2025-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient aged 18 years old or more
• Patient with newly diagnosed previously untreated de novo, secondary or therapy-related AML
• Patients with R/R de novo, secondary or therapy-related AML
• Patient with Health insurance

You may not qualify if…

• Acute promyelocytic leukemia
• AML which is not morphologically proven (patients with granulocytic sarcoma may be included)
• For newly diagnosed AML: previous treatment of leukemia apart from hydroxyurea. Previous anti leukemia treatments are allowed if they were administered before the diagnosis of AML to treat a MDS, MPN, MPN/MDS or CML
• Patient weighting less than 50 kgs
• Opposition of the patient to participate to this non-interventional study
• More specific eligibility criteria might be requested to enter some study modules

Where it is running

• Institut Gustave Roussy — Villejuif, France (enrolling)
• Centre Hospitalier Victor Dupouy — Argenteuil, France (enrolling)
• AP-HP-GHU - Hôpital AVICENNE — Bobigny, France (enrolling)
• CHU de la cote de Nacre — Caen, France (enrolling)
• Hôpital MILITAIRE PERCY — Clamart, France (enrolling)
• Centre hospitalier Sud Francilien — Corbeil-Essonnes, France (enrolling)
• Hôpital Henri Mondor AP-HP — Créteil, France (enrolling)
• Centre Henri Becquerel — Rouen, France (enrolling)
• Centre Hospitalier de St Quentin — Saint-Quentin, France (enrolling)
• Chu Amiens — Amiens, France (enrolling)
• Centre Hospitalier de Dunkerque — Dunkirk, France (enrolling)
• Centre Hospitalier de Versailles André Mignot — Le Chesnay, France (enrolling)
• Centre Hospitalier Dr Schaffner — Lens, France (enrolling)
• CHRU de Lille- Hopital C. HURIEZ — Lille, France (enrolling)
• GHICL-Hopital St Vincent de Paul — Lille, France (enrolling)
• C H U DE LIMOGES- Hopital Dupuytren — Limoges, France (enrolling)
• CHU La Conception — Marseille, France (enrolling)
• Centre Hopsitalier de l'Est Francilien - Site de Meaux — Meaux, France (enrolling)
• Centre Antoine Lacassagne — Nice, France (enrolling)
• CHU Nice,Hopital Archet 1 — Nice, France (enrolling)
• Hopital Pitié-Salpétrière APHP — Paris, France (enrolling)
• Hôpital Necker - APHP — Paris, France (enrolling)
• Hôpital SAINT ANTOINE-APHP — Paris, France (enrolling)
• Hôpital Saint Louis- APHP — Paris, France (enrolling)
• Centre Hospitalier Lyon Sud — Pierre-Bénite, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.